Senti Biosciences is trading 8.59% up at $0.34 after a strong September 17, 2026 market session, with broader markets providing a supportive backdrop.

  • No new company-specific announcement, earnings release, or regulatory catalyst was identified.
  • Recent financing and merger-related filings predate September 17, 2026.
  • The S&P 500 rose 1.13% and Nasdaq Composite gained 1.68%, likely lifting speculative biotechnology shares.